Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of RKDA will decline by -21.10% over the next 2 Weeks and hit $1.40 by Wednesday, March 4, 2026. In that time frame, RKDA's share price is expected to range between $1.21 and $1.62.
BearishAverageBullish| Date | Predicted Lower | Predicted | Predicted Upper |
|---|---|---|---|
| Mar 4, 2026 | 1.21 | 1.40 | 1.62 |
| Mar 3, 2026 | 1.19 | 1.39 | 1.59 |
| Mar 2, 2026 | 1.28 | 1.49 | 1.68 |
| Feb 27, 2026 | 1.40 | 1.57 | 1.77 |
| Feb 26, 2026 | 1.42 | 1.62 | 1.81 |
| Feb 25, 2026 | 1.36 | 1.55 | 1.74 |
| Feb 24, 2026 | 1.35 | 1.54 | 1.74 |
| Feb 23, 2026 | 1.43 | 1.64 | 1.83 |
| Feb 20, 2026 | 1.53 | 1.72 | 1.91 |
| Feb 19, 2026 | 1.57 | 1.77 | 1.95 |
RKDA shares rose +11.25% in Wednesday, February 18, 2026's trading session, rising from a previous close of $1.60 to move at $1.78. The stock demonstrated notable intraday movement (see RKDA's key stats for a full breakdown), fluctuating between $1.64 and $1.78, a +8.54% trading range. While recent weeks have seen some volatility, RKDA has managed to secure a -6.32% drop over the past 2 weeks. The upward price movement was accompanied by decreased trading volume, with approximately 16.84K shares changing hands, 6.92K fewer than the previous session. This amounted to $29.98K in total market activity.
Will RKDA Continue Its Downward Trend?
According to analyst ratings and projections for RKDA, Arcadia Biosciences, Inc. shares are anticipated to decrease by -9.92%, potentially reaching $1.62 per share by March 4, 2026. Short-term technical indicators for RKDA currently suggest a bearish sentiment. This aligns with the stock's recent performance, as it has recorded 21 negative trading days within the past 30 sessions. Based on the RKDA stock forecast, now is not the best time to buy RKDA stock because its current trading price is +26.74% above our predicted value, hinting at a possible undervaluation. For deeper insights, view our sentiment analysis on RKDA covering social and institutional perspectives.
RKDA Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into RKDA's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 36.07% to 40.27%) suggest weak bearish momentum with possible fluctuation. The 50-day RSI, at 40.29%, suggests a neutral medium-term outlook. Additionally, the 100-day RSI, at 44.01%, maintains a neutral outlook for the long term. Insights into RKDA's shareholder base show how institutional investors are positioning themselves during these momentum shifts
Arcadia Biosciences Short-Term Forecasts
RKDA Forecast For Next 5 Days
Our algorithm anticipates Arcadia Biosciences (RKDA) stock could hit $1.26 by Feb 25, 2026. This represents a -28.95% fall from today's price, following a -5.35% change over the past five days.
RKDA Forecast For Next 30 Days
Based on analysis of market trends, the outlook for Arcadia Biosciences, Inc. (RKDA) stock over the next 30 days is largely negative. Price forecasts suggest an average target of $1.07, which would mean a -39.89% decrease from the current price of $1.78. Projections for this period range from a high of $1.81 to a low of $0.46.
RKDA Forecast For Next 90 Days
Our proprietary market analysis suggests predictions for Arcadia Biosciences's price over the next three months point to a rise. RKDA stock is expected to peak at $4.24 on Mar 24, 2026 before potentially dipping to $2.24 on Apr 15, 2026. On average, RKDA is likely to trade around $3.37 in the coming 90 days.
Arcadia Biosciences Stock Forecast 2025
Based on our predictive models, Arcadia Biosciences (RKDA) is expected to trade between $0.00 and $4.72 throughout 2026. This would result in an average price of $3.34, potentially offering investors a +87.64% return from current levels.
Arcadia Biosciences, Inc. Monthly Forecast 2026–2027
February 2026
According to our latest forecast models, Arcadia Biosciences, Inc. (RKDA) is positioned to show a strong performance in February 2026. The price is predicted to move between $3.66 and $4.06, settling at an average of $3.89. This could translate to a +118.54% gain.
March 2026
Based on current market signals, Arcadia Biosciences, Inc. is projected to trend march 2026. We forecast a trading range from $3.13 to $4.24, with a likely average price of $3.81. Investors could expect a potential return of +114.04%.
April 2026
Our predictive algorithms indicate Arcadia Biosciences, Inc. stock may see a shift in April 2026. The expected range spans $2.24–$3.38, with an average target of $2.80. This represents a positive outlook and a possible gain of +57.30%.
May 2026
Analyzing established trends, Arcadia Biosciences, Inc. looks set to move in May 2026. Projections place the stock between $2.87 and $4.19, averaging around $3.51. This suggests a +97.19% gain from current levels.
June 2026
Market indicators suggest Arcadia Biosciences, Inc. could experience notable changes during June 2026. Prices could fluctuate within $2.41 to $4.72, with a midpoint forecast of $3.92. The stock might deliver a +120.22% gain.
July 2026
Forecasting for July 2026, models estimate that Arcadia Biosciences, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $2.35 and $4.37, averaging $3.73. This signals a positive trajectory with potential returns around +109.55%.
August 2026
According to our latest forecast models, Arcadia Biosciences, Inc. (RKDA) is positioned to show a strong performance in August 2026. The price is predicted to move between $1.48 and $4.53, settling at an average of $4.27. This could translate to a +139.89% gain.
September 2026
Based on current market signals, Arcadia Biosciences, Inc. is projected to trend september 2026. We forecast a trading range from $0.70 to $3.12, with a likely average price of $3.13. Investors could expect a potential return of +75.84%.
October 2026
Our predictive algorithms indicate Arcadia Biosciences, Inc. stock may see a shift in October 2026. The expected range spans $0.00–$3.03, with an average target of $3.19. This represents a positive outlook and a possible gain of +79.21%.
November 2026
Analyzing established trends, Arcadia Biosciences, Inc. looks set to move in November 2026. Projections place the stock between $0.00 and $2.86, averaging around $2.53. This suggests a +42.13% gain from current levels.
December 2026
Market indicators suggest Arcadia Biosciences, Inc. could experience notable changes during December 2026. Prices could fluctuate within $0.00 to $1.69, with a midpoint forecast of $2.36. The stock might deliver a +32.58% gain.
January 2027
Forecasting for January 2027, models estimate that Arcadia Biosciences, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $0.00 and $1.67, averaging $2.57. This signals a positive trajectory with potential returns around +44.38%.
February 2027
According to our latest forecast models, Arcadia Biosciences, Inc. (RKDA) is positioned to show a strong performance in February 2027. The price is predicted to move between $0.00 and $0.86, settling at an average of $1.94. This could translate to a +8.99% gain.
RKDA's history of dividends and stock splits also plays a role in long-term investor confidence.

